Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3969 USD | -3.31% | -0.68% | -9.77% |
16/05 | Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024 | |
29/04 | AIM ImmunoTech Says Safety Evaluation of First Dose Level of Pancreatic Cancer Study Completed | MT |